The Personalized Medicine Coalition: goals and strategies.

作者: Edward Abrahams , Geoffrey S Ginsburg , Mike Silver

DOI: 10.2165/00129785-200505060-00002

关键词:

摘要: … and the adoption of personalized medicine approaches. Centers have been established worldwide to study the ethical, legal, and social impact of personalized medicine, including the …

参考文章(30)
Phyllis Griffin Epps, Policy Before Practice American Journal of Pharmacogenomics. ,vol. 3, pp. 405- 418 ,(2003) , 10.2165/00129785-200303060-00008
Andrew Webster, Paul Martin, Graham Lewis, Andrew Smart, Integrating pharmacogenetics into society: in search of a model. Nature Reviews Genetics. ,vol. 5, pp. 663- 669 ,(2004) , 10.1038/NRG1430
W Sadee, D L Veenstra, K A Phillips, Implications of the genetics revolution for health services research: pharmacogenomics and improvements in drug therapy. Health Services Research. ,vol. 35, pp. 128- 140 ,(2000)
Alasdair Breckenridge, Klaus Lindpaintner, Peter Lipton, Howard McLeod, Mark Rothstein, Helen Wallace, Pharmacogenetics: ethical problems and solutions. Nature Reviews Genetics. ,vol. 5, pp. 676- 680 ,(2004) , 10.1038/NRG1431
David W. Feigal, Steven I. Gutman, Drug Development, Regulation, and Genetically Guided Therapy Pharmacogenomics. pp. 99- 108 ,(2003) , 10.1002/047142613X.CH6
Louise Wideroff, Susan Thomas Vadaparampil, Nancy Breen, Robert T. Croyle, Andrew N. Freedman, Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey. Community Genetics. ,vol. 6, pp. 147- 156 ,(2003) , 10.1159/000078162
L J Lesko, J Woodcock, Pharmacogenomic-guided drug development: regulatory perspective Pharmacogenomics Journal. ,vol. 2, pp. 20- 24 ,(2002) , 10.1038/SJ.TPJ.6500046